Covered recipient · General Payments record
JUBILEE BROWN
Allopathic & Osteopathic Physicians Obstetrics & Gynecology Gynecologic Oncology
General Payments · PY2018–2024
$42,352.15
- Reported across 84 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $5,540.00 | 3 |
| Food and Beverage | $542.50 | 7 |
| Education | $64.50 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $3,016.10 | 4 |
| Acerta Pharma LLC | $2,808.99 | 3 |
| Aadi Bioscience, Inc. | $188.98 | 2 |
| ImmunoGen, Inc. | $118.65 | 1 |
| EISAI INC. | $14.28 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Aadi Bioscience, Inc. | $99.98 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119596919 | CMS |
| Aadi Bioscience, Inc. | $89.00 | 03/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119596917 | CMS |
| AstraZeneca Pharmaceuticals LP | $68.99 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105499162 | CMS |
| AstraZeneca Pharmaceuticals LP | $2,055.00 | 02/13/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1104423105 | CMS |
| AstraZeneca Pharmaceuticals LP | $685.00 | 02/29/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1104292690 | CMS |
| Eisai Inc. | $14.28 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110756130 | CMS |
| GlaxoSmithKline, LLC. | $123.60 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116472741 | CMS |
| GlaxoSmithKline, LLC. | $28.00 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116494754 | CMS |
| GlaxoSmithKline, LLC. | $2,800.00 | 02/22/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116319458 | CMS |
| GlaxoSmithKline, LLC. | $64.50 | 09/09/2024 | Education | Undisputed | 01/23/2026 | 1116400402 | CMS |
| ImmunoGen, Inc. | $118.65 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1099941407 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.